Defining correlates of protective immunity in HIV-1 transmission is a priority in HIV-1 vaccine research. Mother-to-child transmission of HIV-1 provides an excellent model in which to study the role of cytotoxic T lymphocyte (CTLs) because infants of HIV-1 infected mothers are repetitively exposed to HIV-1 (in utero, during delivery, and through breast milk) and initial exposure may induce CTLs that protect from subsequent exposure. In Kenya, many HIV-1 seropositive mothers choose to breast feed despite knowledge of breast milk HIV-1 transmission risk and provision of an alternative, because of stigma attached to HIV infection and risk associated with formula feeding. The effect of infant CTLs on breast milk HIV-1 transmission risk can be determined in infants of these mothers. The amount, time, and route of infant viral exposure can be measured, enabling systematic evaluation of determinants of CTL induction in this model. This observational prospective study aims to determine the effect on breast milk HIV-1 transmission of CTLs in infants of HIV-1 infected mothers in Nairobi. After informed consent, pregnant HIV-1 seropositive women will be enrolled in the study. Women in the study will be provided with short course antiretrovirals and will feed the infant according to their preference. Maternal plasma and genital specimens will be collected antenatally and at delivery, and breast milk and plasma specimens collected during the postnatal period for HIV-1 assays. Infants will be serially evaluated for HIV-1 by PCR, and infants who are uninfected at birth assessed for CTL responses at birth, and at 1, 3, and 12 months of age. CTL responses will be quantitated with ELISPOT assays using HLA-typing techniques and epitopes previously developed for Nairobi. Among breast feeding infants, the effect of CTL at birth and at 1 month on subsequent risk of breast milk transmission of HIV-1 will be evaluated in the context of other potential correlates of breast milk transmission. The prevalence and correlates of infant CTLs at birth, 1, 3, and 12 months will be determined. To determine whether ongoing breast milk exposure sustains infant CTL responses, the prevalence of CTLs at one year will be compared in breast and formula feeding uninfected infants. Demonstration of a protective effect of CTLs on breast milk transmission will be specifically relevant to prevention of breast milk transmission of HIV-1 and to HIV-1 vaccine development in general.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
2R01HD023412-11
Application #
2799085
Study Section
Special Emphasis Panel (ZRG5-AARR-6 (01))
Program Officer
Nugent, Robert
Project Start
1987-09-30
Project End
2004-04-30
Budget Start
1999-05-28
Budget End
2000-04-30
Support Year
11
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Beima-Sofie, Kristin; Wamalwa, Dalton; Maleche-Obimbo, Elizabeth et al. (2018) Toll-like receptor 9 polymorphism is associated with increased Epstein-Barr virus and Cytomegalovirus acquisition in HIV-exposed infants. AIDS 32:267-270
Pankau, Mark D; Wamalwa, Dalton; Benki-Nugent, Sarah et al. (2018) Decay of HIV DNA in the Reservoir and the Impact of Short Treatment Interruption in Kenyan Infants. Open Forum Infect Dis 5:ofx268
Gómez, Laurén A; Crowell, Claudia S; Njuguna, Irene et al. (2018) Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children. Pediatr Infect Dis J 37:916-922
LaCourse, Sylvia M; Pavlinac, Patricia B; Cranmer, Lisa M et al. (2018) Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children. AIDS 32:69-78
Wagner, Anjuli D; O?Malley, Gabrielle; Firdawsi, Olivia et al. (2018) Brief Report: Disclosure, Consent, Opportunity Costs, and Inaccurate Risk Assessment Deter Pediatric HIV Testing: A Mixed-Methods Study. J Acquir Immune Defic Syndr 77:393-399
LaCourse, Sylvia M; Cranmer, Lisa M; Njuguna, Irene N et al. (2018) Urine Tuberculosis Lipoarabinomannan Predicts Mortality in Hospitalized Human Immunodeficiency Virus-Infected Children. Clin Infect Dis 66:1798-1801
Njuguna, Irene N; Cranmer, Lisa M; Otieno, Vincent O et al. (2018) Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trial. Lancet HIV 5:e12-e22
Suter, Megan K; Karr, Catherine J; John-Stewart, Grace C et al. (2018) Implications of Combined Exposure to Household Air Pollution and HIV on Neurocognition in Children. Int J Environ Res Public Health 15:
Wagner, Anjuli D; Njuguna, Irene N; Andere, Ruth A et al. (2017) Infant/child rapid serology tests fail to reliably assess HIV exposure among sick hospitalized infants. AIDS 31:F1-F7
Benki-Nugent, Sarah; Wamalwa, Dalton; Langat, Agnes et al. (2017) Comparison of developmental milestone attainment in early treated HIV-infected infants versus HIV-unexposed infants: a prospective cohort study. BMC Pediatr 17:24

Showing the most recent 10 out of 124 publications